Novel immunotherapy delivery approach benefits some melanoma patients with leptomeningeal disease Dr. Kamal Kant Kohli10 April 2023 2:00 AM ISTA novel approach to administer intrathecal (IT) immunotherapy (directly into the spinal fluid) and intravenous (IV) immunotherapy was safe and...
New immunotherapy agent safe and promising against high-risk prostate cancers Isra Zaman8 April 2023 9:15 AM ISTEnoblituzumab, a monoclonal antibody drug works by binding to a protein called B7-H3 that is overexpressed on prostate cancer cells and believed to...
SGLT2 inhibitors use lowers cancer risk in patients with diabetes Medha Baranwal7 April 2023 11:30 AM ISTTaiwan: Patients with diabetes who receive sodium-glucose cotransporter-2 (SGLT2) inhibitors are at a significantly lower risk of cancer, a new study...
Lorlatinib is safe and effective for patients with ALK-driven relapsed/refractory high-risk neuroblastoma, research shows Isra Zaman5 April 2023 9:30 AM ISTNeuroblastoma is an aggressive pediatric cancer that develops from early nerve cells, often appearing as a solid tumor in the chest or abdomen. The...
Immunotherapy after surgery is beneficial for high-risk bladder cancer patients Dr. Kamal Kant Kohli4 April 2023 10:00 AM ISTUSA: Immunotherapy after surgery increases the chance of staying cancer-free in bladder cancer patients compared to those who received a placebo,...
Outcome of patients with a rare type of astrocytoma is worse than expected: Study Isra Zaman4 April 2023 9:15 AM ISTGliomas are a tumor that originate in the glial cells that surround neurons in the brain. Under the microscope, gliomas can be divided into several...
Therapy that overcomes chemotherapy resistance in colon and rectal cancer validated in study Isra Zaman3 April 2023 9:15 AM ISTOxaliplatin along with other medications is often used to treat advanced colon or rectal cancer. A multidisciplinary team made up of doctors and...
CAR T cells improve patient quality of life: Study Isra Zaman1 April 2023 9:15 AM ISTChimeric antigen receptor T-cell (CAR-T) therapies are developed by harvesting a patient's own T cells (the immune system's primary cancer-killing...
Some melanoma patients with leptomeningeal disease benefit from novel immunotherapy delivery approach Isra Zaman31 March 2023 9:15 AM ISTLeptomeningeal disease is a complication of cancer that occurs when cancer cells from primary tumors migrate into the cerebrospinal fluid (CSF) and...
Novel drug combination shows positive results for HPV-negative patients with advanced head and neck cancer Isra Zaman30 March 2023 9:15 AM ISTHead and neck cancer is a deadly form of cancer that arises in the lining of the mouth and throat. Worldwide more than 700,000 people were diagnosed...
Novel probe for labeling macrophages associated with cancer progression using a selective dye Isra Zaman29 March 2023 9:45 AM ISTM1 and M2 are activated macrophages that protect our immune system and maintain homeostasis. Interestingly, they are characterized by distinct and...
Clinical trial of ENZAMET shows it promising as prostate cancer treatment Isra Zaman29 March 2023 9:30 AM ISTA new drug combination for men with advanced prostate cancer has shown sustained increase in survival rates. The results from the clinical trial of...
